Entities / Company
Stereotaxis.
American medical robotics company
- Reports this week
- 0
- Active events
- 0
- Connections
- 25
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Stereotaxis announced that David Fischel was appointed Chairman and CEO, and the company filed an offering pursuant to an SEC registration statement.Some support1 report1 development inside
-
Stereotaxis, led by CEO David Fischel, participated in the MAGiC catheter study at Vilnius University Hospital on July 1, 2025.Speculative1 report
-
Stereotaxis technology has been successfully used to treat patients across the United States, Europe, and Asia.Some support1 report
-
Stereotaxis received FDA clearance for commercial launch and submitted applications regarding its procedures in the U.S. market.Some support2 reports2 developments inside
-
Stereotaxis received FDA clearance for a diagnostic catheter and utilizes Genesis robotic navigation systems.Some support2 reports
-
Stereotaxis shares underperformed the market on August 8, 2025.Some support1 report
-
David Fischel was appointed Chairman and CEO of Stereotaxis on August 8, 2025.Some support1 report
-
Stereotaxis CEO David Fischel and other experts are involved in a conference in Atlanta focused on ablation techniques, pioneered by the Heart Rhythm Society.Some support2 reports
-
Stereotaxis CEO David Fischel is scheduled to present at conferences in New York City.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Stereotaxis this week
News at the entities that move Stereotaxis most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Stereotaxis
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Stereotaxis
-
Europe Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Stereotaxis
-
Citigroup Mentioned togetherCitigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Moves Stereotaxis
-
St. Louis Shared contextA band is calling home to St. Louis.Moves Stereotaxis
Connections
The 7 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
David Fischel Structural
David Fischel holds the executive roles of Chairman and CEO at Stereotaxis.
-
FDA Structural
FDA formally regulates Stereotaxis' medical devices, granting clearance necessary for market entry and commercial launch.
-
Heart Rhythm Society Operational
Stereotaxis showcases its technology and participates in initiatives organized by the Heart Rhythm Society.
-
MarketBeat Mentioned together
MarketBeat provides average rating and target price coverage for Stereotaxis.
-
Europe Shared context
Stereotaxis operates and commercializes its technology within the European market.
-
Citigroup Mentioned together
Citigroup provided analyst ratings on Stereotaxis.
-
St. Louis Shared context
Stereotaxis is located and operates within the geographical context of St. Louis, Missouri.
History
Events by the month they beganJuly 2026
2 eventsJune 2026
9 events- Stereotaxis announced that David Fischel was appointed Chairman and CEO, and the company filed an offering pursuant to an SEC registration statement.
- Stereotaxis, led by CEO David Fischel, participated in the MAGiC catheter study at Vilnius University Hospital on July 1, 2025.
- Stereotaxis technology has been successfully used to treat patients across the United States, Europe, and Asia.
- Stereotaxis received FDA clearance for commercial launch and submitted applications regarding its procedures in the U.S. market.
- Stereotaxis received FDA clearance for a diagnostic catheter and utilizes Genesis robotic navigation systems.
- Stereotaxis shares underperformed the market on August 8, 2025.
- David Fischel was appointed Chairman and CEO of Stereotaxis on August 8, 2025.
- Stereotaxis CEO David Fischel and other experts are involved in a conference in Atlanta focused on ablation techniques, pioneered by the Heart Rhythm Society.
- Stereotaxis CEO David Fischel is scheduled to present at conferences in New York City.